David Protein Says ‘Diet’ Trends Are Over, GLP-1s Upend Markets
David Rahal, founder and CEO of David Protein, argues GLP-1 drugs have upended the diet-trend cycle, reshaping how br...
This intro highlights key habits to prevent budget mistakes and keep your spending aligned with your goals, offering actionable guidance for steady progress.
11,326 articlesDavid Rahal, founder and CEO of David Protein, argues GLP-1 drugs have upended the diet-trend cycle, reshaping how br...
Investing in niche AI infrastructure can offer outsized upside, but only with a plan. This article shows how buying P...
A fleet driver allegedly ran up six figures on a single fuel card, highlighting how fuel-card programs can be misused...
Veteran CBS News analyst Jill Schlesinger is launching a new podcast to help listeners make smarter money decisions a...
Two chipmakers lit up the market in the first half of 2026, but the big question remains: which is the smarter buy no...
A biotech with no current revenue can still carry a sky-high valuation. This article explains how Revolution Medicine...
As markets swing, a trio of unloved names—general mills, mattel, and mohawk—are drawing renewed attention from retire...
The 2-year Treasury yield has topped 4%, drawing retirees into short-duration income funds. Two ETFs lead the pack, o...
June brought a sharp turn for Newmont as gold dynamics and costs collided with production headwinds. This article bre...
June dealt a sharp blow to crypto portfolios, but history suggests volatility can bring opportunity. This guide expla...
Choosing a core bond ETF is a cornerstone of a smart, income-focused portfolio. This guide compares Vanguard BND and ...
Major research firm reaffirmed its price target on Terawulf as the company inks a long-term lease with Anthropic and ...